Metastatic breast cancer trials in Saudi Arabia

4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  Where

  Riyadh

  Age

  18 years and over

  People

  491 worldwide

  Run by

  SWOG Cancer Research Network

  See details and how to joinNCT03418961
• No phaseTaking people
  BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy

  Where

  Jeddah, Mecca, Riyadh

  Age

  18 years and over

  People

  109 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07597993
• Phase 2Taking people
  Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.

  Where

  Riyadh

  Age

  18 years and over

  People

  80 worldwide

  Run by

  International Cancer Research Group, United Arab Emirates

  See details and how to joinNCT05190094
• No phaseNot yet taking people in Saudi Arabia
  Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients

  Where

  Al Madīnah

  People

  54

  Run by

  Assiut University

  See details and how to joinNCT06076772